Michael Bohn, MD, Addiction Psychiatrist With the Adolescent Substance Abuse Program


 

Michael Bohn, MD, addiction psychiatrist with the Adolescent Substance Abuse Program – Michael Bohn, MD, addiction psychiatrist with the Adolescent Substance Abuse Program in Wisconsin discusses the issues faced by families and adolescents who are facing drug and alcohol addictions.

 

Orexo announces submission of a New Drug Application for KW-2246 (Abstral

Filed under: drug treatment news 2010

Swedish specialty pharmaceutical company Orexo today communicated that its partner Kyowa Hakko Kirin Co., Ltd has submitted a New Drug Application (“NDA”) in Japan for KW-2246 (Abstral), a fentanyl sublingual tablet developed for the treatment of …
Read more on Equities.com

 

New DPA Report Highlights the Impact of the War on Drugs on Veterans

Filed under: drug treatment news 2010

The report examines the plight of veterans struggling with incarceration and psychological wounds of war, such as addiction and post-traumatic stress disorder, and suggests reforms that could improve the health and preserve the freedom of American …
Read more on Huffington Post

 

Antiviral Drug Cuts Cancer Risk in Hepatitis B

Filed under: drug treatment news 2010

Antiviral Drug Cuts Cancer Risk in Hepatitis B. By Michael Smith … BOSTON — For patients with chronic hepatitis B, long-term treatment with entecavir (Baraclude) significantly cut the risk of liver cancer, researchers reported. In a retrospective …
Read more on MedPage Today